Literature DB >> 24887490

Supplementation with three different macular carotenoid formulations in patients with early age-related macular degeneration.

Sarah Sabour-Pickett1, Stephen Beatty, Eithne Connolly, James Loughman, Jim Stack, Alan Howard, Ronald Klein, Barbara E Klein, Stacy M Meuer, Chelsea E Myers, Kwadwo O Akuffo, John M Nolan.   

Abstract

PURPOSE: To investigate the impact of three different macular carotenoid formulations on macular pigment optical density and visual performance in subjects with early age-related macular degeneration.
METHODS: Fifty-two subjects were supplemented and followed for 12 months, 17 of them were in intervention Group 1 (20 mg/day lutein and 2 mg/day zeaxanthin); 21 in Group 2 (10 mg/day meso-zeaxanthin, 10 mg/day lutein, and 2 mg/day zeaxanthin); and 14 in Group 3 (17 mg/day meso-zeaxanthin, 3 mg/day lutein, and 2 mg/day zeaxanthin). The macular pigment optical density was measured using customized heterochromatic flicker photometry, and visual function was assessed using corrected distance visual acuity and by letter contrast sensitivity.
RESULTS: A statistically significant increase in the macular pigment optical density was observed at all measured eccentricities in Group 2 (P ≤ 0.005) and in Group 3 (P < 0.05, for all), but only at 1.75° in Group 1 (P = 0.018). Statistically significant (P < 0.05) improvements in letter contrast sensitivity were seen at all spatial frequencies (except 1.2 cycles per degree) in Group 3, and at low spatial frequencies in Groups 1 and 2.
CONCLUSION: Augmentation of the macular pigment optical density across its spatial profile and enhancements in contrast sensitivity were best achieved after supplementation with a formulation containing high doses of meso-zeaxanthin in combination with lutein and zeaxanthin.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24887490     DOI: 10.1097/IAE.0000000000000174

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  23 in total

Review 1.  Lutein and Zeaxanthin Isomers in Eye Health and Disease.

Authors:  Julie Mares
Journal:  Annu Rev Nutr       Date:  2016-07-17       Impact factor: 11.848

2.  Comment on 'The evidence informing the surgeon's selection of intraocular lens on the basis of light transmittance properties'.

Authors:  B R Hammond
Journal:  Eye (Lond)       Date:  2017-04-21       Impact factor: 3.775

Review 3.  Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.

Authors:  Jennifer R Evans; John G Lawrenson
Journal:  Cochrane Database Syst Rev       Date:  2017-07-31

Review 4.  What do we know about the macular pigment in AMD: the past, the present, and the future.

Authors:  Ranganathan Arunkumar; Charles M Calvo; Christopher D Conrady; Paul S Bernstein
Journal:  Eye (Lond)       Date:  2018-03-26       Impact factor: 3.775

5.  Non-Dietary Correlates and Determinants of Plasma Lutein and Zeaxanthin Concentrations in the Irish Population.

Authors:  R Moran; J M Nolan; J Stack; A M O'Halloran; J Feeney; K O Akuffo; R A Kenny; S Beatty
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

6.  REPRODUCIBILITY OF MACULAR PIGMENT OPTICAL DENSITY MEASUREMENT BY TWO-WAVELENGTH AUTOFLUORESCENCE IN A CLINICAL SETTING.

Authors:  Qi Sheng You; Dirk-Uwe G Bartsch; Mark Espina; Mostafa Alam; Natalia Camacho; Nadia Mendoza; William R Freeman
Journal:  Retina       Date:  2016-07       Impact factor: 4.256

Review 7.  Lutein, zeaxanthin, and meso-zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease.

Authors:  Paul S Bernstein; Binxing Li; Preejith P Vachali; Aruna Gorusupudi; Rajalekshmy Shyam; Bradley S Henriksen; John M Nolan
Journal:  Prog Retin Eye Res       Date:  2015-11-02       Impact factor: 21.198

8.  MACULAR PIGMENT DISTRIBUTION RESPONSES TO HIGH-DOSE ZEAXANTHIN SUPPLEMENTATION IN PATIENTS WITH MACULAR TELANGIECTASIA TYPE 2.

Authors:  Rene Y Choi; Aruna Gorusupudi; Kimberley Wegner; Mohsen Sharifzadeh; Werner Gellermann; Paul S Bernstein
Journal:  Retina       Date:  2017-12       Impact factor: 4.256

9.  Sustained supplementation and monitored response with differing carotenoid formulations in early age-related macular degeneration.

Authors:  K O Akuffo; J M Nolan; A N Howard; R Moran; J Stack; R Klein; B E Klein; S M Meuer; S Sabour-Pickett; D I Thurnham; S Beatty
Journal:  Eye (Lond)       Date:  2015-05-15       Impact factor: 3.775

10.  An exploratory study evaluating the effects of macular carotenoid supplementation in various retinal diseases.

Authors:  Roxanne Crosby-Nwaobi; Philip Hykin; Tunde Peto; Sobha Sivaprasad
Journal:  Clin Ophthalmol       Date:  2016-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.